GO
Loading...

Enter multiple symbols separated by commas

Europe Top News and Analysis Ireland

More

  • DUBLIN _ Prothena Corp. on Tuesday reported a second-quarter loss of $18.3 million, after reporting a profit in the same period a year earlier. On a per-share basis, the Dublin- based company said it had a loss of 59 cents. Prothena shares have more than tripled since the beginning of the year.

  • DUBLIN _ Global Indemnity PLC on Tuesday reported second-quarter net income of $11.1 million. Global Indemnity shares have decreased roughly 1 percent since the beginning of the year. Keywords: Global Indemnity, Earnings Report.

  • DUBLIN— Shares of Mallinckrodt slid 12 percent Tuesday after the Irish drugmaker reported disappointing quarterly revenue and said growth in sales of its HP Acthar Gel, the target of a $5.6 billion acquisition last year, may be lower than it expected. In August, Mallinckrodt bought Questcor Pharmaceuticals, the company that markets Acthar, for $5.6 billion.

  • XL beats 2Q profit forecasts Monday, 3 Aug 2015 | 4:33 PM ET

    DUBLIN _ XL Group PLC on Monday reported second-quarter net income of $915 million, after reporting a loss in the same period a year earlier. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of 77 cents per share. This story was generated by Automated Insights using data from Zacks Investment Research.

  • Shire buying Foresight for $300 million Monday, 3 Aug 2015 | 10:05 AM ET

    NEW YORK— Shire PLC is buying privately-held Foresight Biotherapeutics Inc. for $300 million, gaining a developing treatment for conjunctivitis, or pinkeye. Shire, based in Dublin, said that FST-100, if approved by regulators, would be the first agent to treat both viral and bacterial conjunctivitis. There are 5.9 million cases of infectious conjunctivitis...

  • Seagate beats Street 4Q forecasts Friday, 31 Jul 2015 | 8:15 AM ET

    DUBLIN _ Seagate Technology PLC on Friday reported fiscal fourth-quarter profit of $138 million. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 65 cents per share. Seagate shares have fallen 23 percent since the beginning of the year, while the Standard& Poor's 500 index has increased slightly more than 2 percent.

  • Tyco beats 3Q profit forecasts Friday, 31 Jul 2015 | 6:15 AM ET

    CORK, Ireland _ Tyco International Ltd. on Friday reported fiscal third-quarter earnings of $156 million. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 56 cents per share. Seven analysts surveyed by Zacks expected $2.54 billion.

  • Alkermes reports 2Q loss Thursday, 30 Jul 2015 | 9:15 AM ET

    DUBLIN _ Alkermes PLC on Thursday reported a second-quarter loss of $46.1 million, after reporting a profit in the same period a year earlier. Alkermes expects a full-year loss of 38 cents per share. Alkermes shares have risen 17 percent since the beginning of the year.

  • Eaton tops 2Q profit forecasts Wednesday, 29 Jul 2015 | 6:36 AM ET

    DUBLIN _ Eaton Corp. PLC on Wednesday reported second-quarter profit of $535 million. The average estimate of 13 analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share. Ten analysts surveyed by Zacks expected $5.51 billion.

  • July 28- Ingersoll-Rand Plc, the maker of Trane airconditioners and Thermo King refrigeration units, forecast a lower-than-expected current-quarter profit, citing slow growth in its industrial business. The Dublin, Ireland- based company said it expects third-quarter adjusted earnings of $1.15 to $1.19 per share. The company's net profit attributable to...

  • Ingersoll-Rand misses Street 2Q forecasts Tuesday, 28 Jul 2015 | 7:12 AM ET

    DUBLIN— Ingersoll-Rand shares tumbled 6 percent after the company issued a weak forecast for the quarter and its second-quarter performance sent investors scattering. Earnings, adjusted for non-recurring costs and to account for discontinued operations, came to $1.20 per share, which was 3 cents shy of expectations, according to a poll by Zacks Investment...

  • Icon PLC beats 2Q profit forecasts Tuesday, 28 Jul 2015 | 6:09 AM ET

    DUBLIN _ Icon PLC on Tuesday reported second-quarter earnings of $58.6 million. Icon PLC expects full-year earnings to be $3.60 to $3.70 per share, with revenue in the range of $1.57 billion to $1.6 billion. Icon PLC shares have increased 27 percent since the beginning of the year.

  • TEL AVIV, July 27- Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms. It also will allow Dublin- based Allergan, the third-largest generic drugmaker in the United States, to focus on branded drugs...

  • JERUSALEM— Israel's Teva Pharmaceutical Industries Ltd. said Monday it is purchasing Dublin- based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company. Statements from both companies say the deal will see Allergan receive $33.75 billion in cash and shares...

  • Allergan to acquire Naurex as Teva talks continue Sunday, 26 Jul 2015 | 3:18 PM ET

    Allergan PLC, the Dublin- based pharmaceutical giant, announced Sunday it has agreed to buy Naurex, a developer of drugs for depression and other central nervous system disorders, for $560 million. The announcement comes among reports that Allergan is in talks to sell its enormous generic drug division to Israel- based Teva Pharmaceutical Industries Ltd. The...

  • TEL AVIV, July 26- After months of sparring in a hostile takeover bid for rival Mylan NV, Teva Pharmaceutical's move to buy Allergan Plc's generic drug business instead could be a smoother ride that will bring bigger returns, faster. Israel- based Teva, the world's largest generic drugmaker, is in advanced talks to buy Allergan's generic drugs unit for between $40-...

  • July 25- Teva Pharmaceutical Industries Ltd is in advanced talks to buy Allergan Plc's generic drug business following a thus far unsuccessful effort to acquire peer Mylan NV, according to a person familiar with the matter. Jerusalem- based Teva, which has offered to buy Mylan for $40 billion, is now close to an agreement to acquire Dublin- based Allergan's...

  • ATHENS, July 16- European creditors moved cautiously towards re-opening funding to Greece's stricken economy on Thursday, hours after a fractious Greek parliament approved a tough bailout program aimed at preventing a chaotic exit from the euro. Prime Minister Alexis Tsipras won the backing of parliament in the early hours of Thursday for the stringent...

  • *Emergency funding to stay as Greece readies reforms. However, the lawmakers are under pressure to act fast as the ECB, facing resistance from Germany, would be unlikely to extend the funding line next week if Greece misses a debt repayment due to the ECB on July 20. The lawmakers' support for tough reforms, agreed by leftist Prime Minister Alexis Tsipras on Monday...

  • *Expected to pursue issue of debt relief for Greece. ATHENS, July 6- Euclid Tsakalotos, the mild-tempered professor who was appointed as Greece's new finance minister on Monday, is a clear change in style from his combative predecessor Yanis Varoufakis. The 55- year-old Tsakalotos studied at prestigious private London school St Paul's and at Oxford University,...